205 related articles for article (PubMed ID: 14520693)
1. Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo.
Lee JS; Weiss J; Martin JL; Scott CD
Int J Cancer; 2003 Nov; 107(4):564-70. PubMed ID: 14520693
[TBL] [Abstract][Full Text] [Related]
2. Silencing the mannose 6-phosphate/IGF-II receptor differentially affects tumorigenic properties of normal breast epithelial cells.
Caixeiro NJ; Martin JL; Scott CD
Int J Cancer; 2013 Dec; 133(11):2542-50. PubMed ID: 23686499
[TBL] [Abstract][Full Text] [Related]
3. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
[TBL] [Abstract][Full Text] [Related]
4. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
5. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
[TBL] [Abstract][Full Text] [Related]
6. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
[TBL] [Abstract][Full Text] [Related]
7. Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development.
Hébert E
Biosci Rep; 2006 Feb; 26(1):7-17. PubMed ID: 16779663
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factors (IGFs) stimulate the release of alpha 1-antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cells.
Confort C; Rochefort H; Vignon F
Endocrinology; 1995 Sep; 136(9):3759-66. PubMed ID: 7649082
[TBL] [Abstract][Full Text] [Related]
9. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells.
Chen Z; Ge Y; Landman N; Kang JX
BMC Cancer; 2002 Jul; 2():18. PubMed ID: 12149131
[TBL] [Abstract][Full Text] [Related]
11. Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors.
Osipo C; Dorman S; Frankfater A
Exp Cell Res; 2001 Apr; 264(2):388-96. PubMed ID: 11262195
[TBL] [Abstract][Full Text] [Related]
12. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
Ghahary A; Tredget EE; Mi L; Yang L
Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
Xie S; Kang JX
Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
[TBL] [Abstract][Full Text] [Related]
14. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer.
Reinmuth N; Liu W; Fan F; Jung YD; Ahmad SA; Stoeltzing O; Bucana CD; Radinsky R; Ellis LM
Clin Cancer Res; 2002 Oct; 8(10):3259-69. PubMed ID: 12374697
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo.
Jerome L; Alami N; Belanger S; Page V; Yu Q; Paterson J; Shiry L; Pegram M; Leyland-Jones B
Cancer Res; 2006 Jul; 66(14):7245-52. PubMed ID: 16849573
[TBL] [Abstract][Full Text] [Related]
16. Mannose-6-phosphate/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells.
Greupink R; Bakker HI; van Goor H; de Borst MH; Beljaars L; Poelstra K
Pharm Res; 2006 Aug; 23(8):1827-34. PubMed ID: 16850269
[TBL] [Abstract][Full Text] [Related]
17. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
18. IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells.
Jackson JG; Yee D
Growth Horm IGF Res; 1999 Oct; 9(5):280-9. PubMed ID: 10543935
[TBL] [Abstract][Full Text] [Related]
19. Enhanced activity of lysosomal proteases in activated rat hepatic stellate cells is associated with a concomitant increase in the number of the mannose-6-phosphate/insulin-like growth factor II receptor.
Mousavi SA; Fønhus MS; Kindberg GM; Tolleshaug H; Berg T
Cell Biol Int; 2013 Jul; 37(7):703-12. PubMed ID: 23495048
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
